Description
PT-141, also known as Bremelanotide, is a synthetic peptide derived from melanocortin analog development and is studied for its interaction with melanocortin receptors, particularly MC3R and MC4R. It is commonly examined in research involving central signaling pathways and receptor-mediated communication.
In laboratory settings, PT-141 is explored for its ability to activate melanocortin receptor pathways, which are associated with a range of signaling processes related to neurochemical modulation and cellular response. These receptors are part of the broader melanocortin system, which plays a role in various regulatory mechanisms within controlled experimental models.
PT-141 has been studied in research involving:
- Melanocortin receptor activation (MC3R, MC4R)
- G-protein coupled receptor signaling pathways
- Neurochemical signaling and modulation models
- Receptor binding affinity and downstream cascade activity
- Central signaling pathway interactions in controlled environments
Due to its targeted receptor activity and defined mechanism within melanocortin pathways, PT-141 is frequently utilized in studies focusing on receptor-specific activation and signaling response patterns.
Each vial contains lyophilized PT-141 intended strictly for laboratory research purposes.
Research Use Only (RUO). Not for human or veterinary use.
Reviews
There are no reviews yet.